<DOC>
	<DOCNO>NCT00975143</DOCNO>
	<brief_summary>The purpose study compare efficacy safety CIP-Isotretinoin market ( generic ) formulation isotretinoin administer twice daily meal .</brief_summary>
	<brief_title>Efficacy Safety CIP-Isotretinoin Patients With Severe Recalcitrant Nodular Acne</brief_title>
	<detailed_description />
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Severe recalcitrant nodular acne , opinion investigator compatible isotretinoin treatment . Ten ( 10 ) nodular lesion ( facial and/or truncal ) . Treatmentnaïve patient without prior exposure systemic isotretinoin retinoids . Age 12 54 year . Weight 40 110 kg . Negative serum human chorionic gonadotropin ( hCG ) pregnancy test consistent nonpregnant state ( female ) . No significant disease clinically significant find physical examination . No clinically significant abnormal laboratory value . No clinically significant abnormal vital sign measurement . Patients present stable control diabetes mellitus ( Types I II ) may include study . However , patient hospitalization diabetes relate complication last 12 month , must stable medication precede 6 month . To include study , patient HemoglobinA1c value ≤ 6.5 % screen test do 3 4 month previously . Patients previously diagnose Polycystic Ovarian Syndrome ( PCOS ) may include study opinion investigator clinically significant abnormality ( e.g . metabolic syndrome elevate lipid ) . Female patient exclude study : Are pregnant ; Are high risk become pregnant likely become pregnant treatment ; Will breastfeed consider breast feeding course study . Known history presence clinically significant unstable medical condition ( ) opinion investigator could pose risk safety patient include previous history gastrointestinal disease . Patients skin disease condition might interfere evaluation recalcitrant nodular acne . Patients interview use SCIDCT current lifetime module Major Depression , Mania , Psychosis . Patients lifetime history psychosis exclude . Patients history major depressive , manic , hypomanic mixed episode exclude unless episode precede year . Patients past current psychotic symptom . Patients report suicidal behaviour ( include attempt , interrupt attempt , abort attempt , preparatory behaviour ) , within past year , serious suicidal ideation past year , exclude study participation . A lifetime history wish dead , nonspecific active suicidal thought active suicidal ideation without intent act result exclusion . Known history suspect carcinoma . Known history liver kidney disorder ( hepatic renal insufficiency ) . Known history current pseudotumor cerebri ( benign intracranial hypertension ) . Patients HLAB27 related disease , rheumatoid arthritis , rickets vitamin D depletion disease phosphate metabolic disease , severe scoliosis &gt; 15 Cobb angle , history back surgery/injuries , ongoing use anticonvulsant know affect bone metabolism genetic acquire rheumatologic joint disease . All pediatric patient serum 25hydroxyvitamin D level &lt; 20 ng/mL . Patients hear disorder opinion investigator would able participate audiometric test study . Hypersensitivity idiosyncratic reaction isotretinoin , Vitamin A and/or drug substance similar activity . Allergy soy bean , soy bean oil ingredient study medication . On special diet within four week prior drug administration ( e.g. , liquid , protein , raw food diet ) . Difficulty consume two ( 2 ) meal day sustain weight health .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>isotretinoin</keyword>
	<keyword>dermatology</keyword>
	<keyword>skin</keyword>
</DOC>